Literature DB >> 19420922

Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH.

D C Bittel1, S Yu, H Newkirk, N Kibiryeva, A Holt, M G Butler, L D Cooley.   

Abstract

Hemizygous deletions of the chromosome 22q11.2 region result in the 22q11.2 deletion syndrome also referred to as DiGeorge, Velocardiofacial or Shprintzen syndromes. The phenotype is variable but commonly includes conotruncal cardiac defects, palatal abnormalities, learning and behavioral problems, immune deficiency, and facial anomalies. Four distinct highly homologous blocks of low copy number repeat sequences (LCRs) flank the deletion region. Mispairing of LCRs during meiosis with unequal meiotic exchange is assumed to cause the recurrent and consistent deletions. The proximal LCR is reportedly located at 22q11.2 from 17.037 to 17.083 Mb while the distal LCR is located from 19.835 to 19.880 Mb. Although the chromosome breakpoints are thought to localize to the LCRs, the positions of the breakpoints have been investigated in only a few individuals. Therefore, we used high resolution oligonucleotide-based 244K microarray comparative genomic hybridization (aCGH) to resolve the breakpoints in a cohort of 20 subjects with known 22q11.2 deletions. We also investigated copy number variation (CNV) in the rest of the genome. The 22q11.2 breaks occurred on either side of the LCR in our subjects, although more commonly on the distal side of the reported proximal LCR. The proximal breakpoints in our subjects spanned the region from 17.036 to 17.398 Mb. This region includes the genes DGCR6 (DiGeorge syndrome critical region protein 6) and PRODH (proline dehydrogenase 1), along with three open reading frames that may encode proteins of unknown function. The distal breakpoints spanned the region from 19.788 to 20.122 Mb. This region includes the genes GGT2 (gamma-glutamyltransferase-like protein 2), HIC2 (hypermethylated in cancer 2), and multiple transcripts of unknown function. The genes in these two breakpoint regions are variably hemizygous depending on the location of the breakpoints. Our 20 subjects had 254 CNVs throughout the genome, 94 duplications and 160 deletions, ranging in size from 1 kb to 2.4 Mb. The presence or absence of genes at the breakpoints depending on the size of the deletion plus variation in the rest of the genome due to CNVs likely contribute to the variable phenotype associated with the 22q11.2 deletion or DiGeorge syndrome. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420922      PMCID: PMC2919456          DOI: 10.1159/000207515

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  31 in total

1.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.

Authors:  C Carlson; H Sirotkin; R Pandita; R Goldberg; J McKie; R Wadey; S R Patanjali; S M Weissman; K Anyane-Yeboa; D Warburton; P Scambler; R Shprintzen; R Kucherlapati; B E Morrow
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA.

Authors:  Michael T Barrett; Alicia Scheffer; Amir Ben-Dor; Nick Sampas; Doron Lipson; Robert Kincaid; Peter Tsang; Bo Curry; Kristin Baird; Paul S Meltzer; Zohar Yakhini; Laurakay Bruhn; Stephen Laderman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

3.  High rates of schizophrenia in adults with velo-cardio-facial syndrome.

Authors:  K C Murphy; L A Jones; M J Owen
Journal:  Arch Gen Psychiatry       Date:  1999-10

Review 4.  The molecular genetics of the 22q11-associated schizophrenia.

Authors:  Maria Karayiorgou; Joseph A Gogos
Journal:  Brain Res Mol Brain Res       Date:  2004-12-20

5.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis.

Authors:  T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

6.  Large-scale copy number polymorphism in the human genome.

Authors:  Jonathan Sebat; B Lakshmi; Jennifer Troge; Joan Alexander; Janet Young; Pär Lundin; Susanne Månér; Hillary Massa; Megan Walker; Maoyen Chi; Nicholas Navin; Robert Lucito; John Healy; James Hicks; Kenny Ye; Andrew Reiner; T Conrad Gilliam; Barbara Trask; Nick Patterson; Anders Zetterberg; Michael Wigler
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

7.  Non-random asynchronous replication at 22q11.2 favours unequal meiotic crossovers leading to the human 22q11.2 deletion.

Authors:  A Baumer; M Riegel; A Schinzel
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

Review 8.  PRODH variants and risk for schizophrenia.

Authors:  Alecia Willis; Hans Uli Bender; Gary Steel; David Valle
Journal:  Amino Acids       Date:  2008-06-05       Impact factor: 3.520

9.  DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets.

Authors:  Kiran Kumar Mantripragada; Isabel Tapia-Páez; Elisabeth Blennow; Peter Nilsson; Anna Wedell; Jan P Dumanski
Journal:  Int J Mol Med       Date:  2004-02       Impact factor: 4.101

10.  Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice.

Authors:  Marta Paterlini; Stanislav S Zakharenko; Wen-Sung Lai; Jie Qin; Hui Zhang; Jun Mukai; Koen G C Westphal; Berend Olivier; David Sulzer; Paul Pavlidis; Steven A Siegelbaum; Maria Karayiorgou; Joseph A Gogos
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

View more
  31 in total

Review 1.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

2.  The use of two different MLPA kits in 22q11.2 deletion syndrome.

Authors:  L J M Evers; J J M Engelen; L M H Houben; L M G Curfs; T A M J van Amelsvoort
Journal:  Eur J Med Genet       Date:  2016-02-24       Impact factor: 2.708

3.  A complex 6p25 rearrangement in a child with multiple epiphyseal dysplasia.

Authors:  Jirair K Bedoyan; Marci M Lesperance; Todd Ackley; Ramaswamy K Iyer; Jeffrey W Innis; Vinod K Misra
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

4.  Deletion of TOP3B Is Associated with Cognitive Impairment and Facial Dysmorphism.

Authors:  Carolyn S Kaufman; Ann Genovese; Merlin G Butler
Journal:  Cytogenet Genome Res       Date:  2016-11-24       Impact factor: 1.636

Review 5.  A Synaptic Function Approach to Investigating Complex Psychiatric Diseases.

Authors:  Laurie R Earls; Stanislav S Zakharenko
Journal:  Neuroscientist       Date:  2013-08-01       Impact factor: 7.519

6.  Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.

Authors:  Jonathan H Chung; Jinlu Cai; Barrie G Suskin; Zhengdong Zhang; Karlene Coleman; Bernice E Morrow
Journal:  Hum Mutat       Date:  2015-07-02       Impact factor: 4.878

7.  An exploratory study of predisposing genetic factors for DiGeorge/velocardiofacial syndrome.

Authors:  Laia Vergés; Francesca Vidal; Esther Geán; Alexandra Alemany-Schmidt; Maria Oliver-Bonet; Joan Blanco
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

8.  Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects.

Authors:  Ibtessam R Hussein; Rima S Bader; Adeel G Chaudhary; Randa Bassiouni; Maha Alquaiti; Fai Ashgan; Hans-Juergen Schulten; Mohammad H Al Qahtani
Journal:  Pediatr Cardiol       Date:  2018-03-14       Impact factor: 1.655

9.  White matter microstructural abnormalities in girls with chromosome 22q11.2 deletion syndrome, Fragile X or Turner syndrome as evidenced by diffusion tensor imaging.

Authors:  Julio Villalon-Reina; Neda Jahanshad; Elliott Beaton; Arthur W Toga; Paul M Thompson; Tony J Simon
Journal:  Neuroimage       Date:  2013-04-18       Impact factor: 6.556

10.  A French multicenter study of over 700 patients with 22q11 deletions diagnosed using FISH or aCGH.

Authors:  Céline Poirsier; Justine Besseau-Ayasse; Caroline Schluth-Bolard; Jérôme Toutain; Chantal Missirian; Cédric Le Caignec; Anne Bazin; Marie Christine de Blois; Paul Kuentz; Marie Catty; Agnès Choiset; Ghislaine Plessis; Audrey Basinko; Pascaline Letard; Elisabeth Flori; Mélanie Jimenez; Mylène Valduga; Emilie Landais; Hakima Lallaoui; François Cartault; James Lespinasse; Dominique Martin-Coignard; Patrick Callier; Céline Pebrel-Richard; Marie-France Portnoi; Tiffany Busa; Aline Receveur; Florence Amblard; Catherine Yardin; Radu Harbuz; Fabienne Prieur; Nathalie Le Meur; Eva Pipiras; Pascale Kleinfinger; François Vialard; Martine Doco-Fenzy
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.